TDP-43 is a key player in the clinical features associated with Alzheimer's disease

Acta Neuropathologica

Volumn 127, Issue 6, 2014, Pages 811-824

  Josephs, Keith A ^a   Whitwell, Jennifer L ^a   Weigand, Stephen D ^a   Murray, Melissa E ^b   Tosakulwong, Nirubol ^a   Liesinger, Amanda M ^b   Petrucelli, Leonard ^b   Senjem, Matthew L ^a   Knopman, David S ^a   Boeve, Bradley F ^a   Ivnik, Robert J ^a   Smith, Glenn E ^a   Jack, Clifford R ^a   Parisi, Joseph E ^a   Petersen, Ronald C ^a   Dickson, Dennis W ^b  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Alzheimer disease; APOE 4; Braak stage; MRI; Resilience; TDP 43

Indexed keywords

APOLIPOPROTEIN E4; TAR DNA BINDING PROTEIN; DNA BINDING PROTEIN; TDP-43 PROTEIN, HUMAN;

AGED; ALZHEIMER DISEASE; AMNESIA; AMYGDALOID NUCLEUS; ARTICLE; BASAL GANGLION; BRAIN ATROPHY; BRAIN SIZE; CLINICAL FEATURE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; CORPUS STRIATUM; DENTATE GYRUS; ENTORHINAL CORTEX; FASCIA DENTATA; FEMALE; FOREBRAIN; FRONTAL LOBE; GRAY MATTER; HIPPOCAMPAL SCLEROSIS; HUMAN; HUMAN TISSUE; INFERIOR OLIVE; INFERIOR TEMPORAL CORTEX; INSULA; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCIPITAL CORTEX; PRIORITY JOURNAL; SUBICULUM; SUBSTANTIA NIGRA; TEGMENTUM; TEMPORAL CORTEX; TEMPORAL LOBE; VERY ELDERLY; VOXEL BASED MORPHOMETRY; ATROPHY; BRAIN; GENETICS; IMMUNOHISTOCHEMISTRY; MEMORY DISORDER; METABOLISM; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGY; REGRESSION ANALYSIS; SCLEROSIS; SEVERITY OF ILLNESS INDEX;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; ATROPHY; BRAIN; COGNITION; DNA-BINDING PROTEINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MAGNETIC RESONANCE IMAGING; MALE; MEMORY DISORDERS; MIDDLE AGED; REGRESSION ANALYSIS; SCLEROSIS; SEVERITY OF ILLNESS INDEX;

EID: 84901680165     PISSN: 00016322     EISSN: 14320533     Source Type: Journal    
DOI: 10.1007/s00401-014-1269-z     Document Type: Article

References (48)

1. Agresti A, Coull BA (1998) Approximate is better than "exact" for interval estimation of binomial proportions. Am Stat 52:119-126
2. Alzheimer A (1907) Über eine eigenartige Erkrankung der Hirnrinde. Allgemeine Zeitschrift für Psychiatrie und Psychisch-Gerichtliche Medizin 64:146-148
3. Amador-Ortiz C, Lin WL, Ahmed Z et al (2007) TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease. Ann Neurol 61:435-445. doi:10.1002/ana.21154 (Pubitemid 46878771)
4. Arai T, Mackenzie IR, Hasegawa M et al (2009) Phosphorylated TDP-43 in Alzheimer's disease and dementia with Lewy bodies. Acta Neuropathol 117:125-136. doi:10.1007/s00401-008-0480-1
5. Arnold SE, Louneva N, Cao K et al (2013) Cellular, synaptic, and biochemical features of resilient cognition in Alzheimer's disease. Neurobiol Aging 34:157-168. doi:10.1016/j.neurobiolaging.2012.03.004
6. Ashburner J, Friston KJ (2000) Voxel-based morphometry - the methods. NeuroImage 11:805-821 (Pubitemid 30437668)
7. Ashburner J, Friston KJ (2005) Unified segmentation. NeuroImage 26:839-851 (Pubitemid 40825026)
8. Bigio EH, Mishra M, Hatanpaa KJ et al (2010) TDP-43 pathology in primary progressive aphasia and frontotemporal dementia with pathologic Alzheimer disease. Acta Neuropathol 120:43-54. doi:10.1007/s00401-010-0681-2
9. Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239-259
10. Brenowitz WD, Monsell SE, Schmitt FA, Kukull WA, Nelson PT (2014) Hippocampal sclerosis of aging is a key Alzheimer's Disease mimic: clinical-pathologic correlations and comparisons with both Alzheimer's Disease and non-tauopathic frontotemporal lobar degeneration. J Alzheimers Dis 39:691-702. doi:10.3233/JAD-131880
11. Buratti E, Brindisi A, Pagani F, Baralle FE (2004) Nuclear factor TDP-43 binds to the polymorphic TG repeats in CFTR intron 8 and causes skipping of exon 9: a functional link with disease penetrance. Am J Hum Genet 74:1322-1325. doi:10.1086/420978 (Pubitemid 38669335)
12. Corder EH, Saunders AM, Strittmatter WJ et al (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261:921-923 (Pubitemid 23275809)
13. Crook R, Hardy J, Duff K (1994) Single-day apolipoprotein E genotyping. J Neurosci Methods 53:125-127 (Pubitemid 24270522)
14. Davidson YS, Raby S, Foulds PG et al (2011) TDP-43 pathological changes in early onset familial and sporadic Alzheimer's disease, late onset Alzheimer's disease and Down's syndrome: association with age, hippocampal sclerosis and clinical phenotype. Acta Neuropathol 122:703-713. doi:10.1007/s00401-011-0879-y
15. Davis DG, Schmitt FA, Wekstein DR, Markesbery WR (1999) Alzheimer neuropathologic alterations in aged cognitively normal subjects. J Neuropathol Exp Neurol 58:376-388 (Pubitemid 29187900)
16. Dickson DW, Davies P, Bevona C et al (1994) Hippocampal sclerosis: a common pathological feature of dementia in very old (≥80 years of age) humans. Acta Neuropathol 88:212-221 (Pubitemid 24265424)
17. Folstein MF, Folstein SE, McHugh PR (1975) "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189-198
18. Gosche KM, Mortimer JA, Smith CD, Markesbery WR, Snowdon DA (2002) Hippocampal volume as an index of Alzheimer neuropathology: findings from the Nun Study. Neurology 58:1476-1482 (Pubitemid 34552952)
19. Hu WT, Josephs KA, Knopman DS et al (2008) Temporal lobar predominance of TDP-43 neuronal cytoplasmic inclusions in Alzheimer disease. Acta Neuropathol 116:215-220. doi:10.1007/s00401-008-0400-4
20. Jack CR Jr, Dickson DW, Parisi JE et al (2002) Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia. Neurology 58:750-757 (Pubitemid 34211554)
21. Jack CR Jr, Lowe VJ, Senjem ML et al (2008) 11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment. Brain J Neurol 131:665-680. doi:10.1093/brain/awm336 (Pubitemid 351294719)
22. Janocko NJ, Brodersen KA, Soto-Ortolaza AI et al (2012) Neuropathologically defined subtypes of Alzheimer's disease differ significantly from neurofibrillary tangle-predominant dementia. Acta Neuropathol 124:681-692. doi:10.1007/s00401-012-1044-y
23. Josephs KA, Tsuboi Y, Cookson N, Watt H, Dickson DW (2004) Apolipoprotein E epsilon 4 is a determinant for Alzheimer-type pathologic features in tauopathies, synucleinopathies, and frontotemporal degeneration. Arch Neurol 61:1579-1584. doi:10.1001/archneur.61.10.1579 (Pubitemid 39350269)
24. Josephs KA, Whitwell JL, Knopman DS et al (2008) Abnormal TDP-43 immunoreactivity in AD modifies clinicopathologic and radiologic phenotype. Neurology 70:1850-1857. doi:10.1212/01.wnl.0000304041.09418.b1 (Pubitemid 351653955)
25. Josephs KA, Whitwell JL, Parisi JE et al (2008) Argyrophilic grains: a distinct disease or an additive pathology? Neurobiol Aging 29:566-573. doi:10.1016/j.neurobiolaging.2006.10.032 (Pubitemid 351312827)
26. Josephs KA, Murray ME, Whitwell JL et al (2014) Staging TDP-43 pathology in Alzheimer's disease. Acta Neuropathol 127:441-450. doi:10.1007/s00401-013- 1211-9
27. Kaplan E, Goodglass H, Weintraub S (1983) The Boston Naming Test. Lea & Febiger, Philadelphia
28. Kaufer DI, Cummings JL, Ketchel P et al (2000) Validation of the NPI-Q, a brief clinical form of the Neuropsychiatric Inventory. J Neuropsychiatry Clin Neurosci 12:233-239 (Pubitemid 30303778)
29. Mattis S (1988) Dementia Rating Scale. Psychological Assessment Resources, City
30. Mirra SS, Heyman A, McKeel D et al (1991) The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41:479-486
31. Morris JC (1993) The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 43:2412-2414
32. Murray ME, Graff-Radford NR, Ross OA, Petersen RC, Duara R, Dickson DW (2011) Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: a retrospective study. Lancet Neurol 10:785-796
33. Nelson PT, Schmitt FA, Lin Y et al (2011) Hippocampal sclerosis in advanced age: clinical and pathological features. Brain J Neurol 134:1506-1518. doi:10.1093/brain/awr053
34. Neumann M, Sampathu DM, Kwong LK et al (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314:130-133. doi:10.1126/science.1134108 (Pubitemid 44547757)
35. Pao WC, Dickson DW, Crook JE, Finch NA, Rademakers R, Graff-Radford NR (2011) Hippocampal sclerosis in the elderly: genetic and pathologic findings, some mimicking Alzheimer disease clinically. Alzheimer Dis Assoc Disord 25:364-368. doi:10.1097/WAD.0b013e31820f8f50
36. Pavlopoulos E, Jones S, Kosmidis S et al (2013) Molecular mechanism for age-related memory loss: the histone-binding protein RbAp48. Sci Transl Med 5:200ra115. doi:10.1126/scitranslmed.3006373
37. Perez-Nievas BG, Stein TD, Tai HC et al (2013) Dissecting phenotypic traits linked to human resilience to Alzheimer's pathology. Brain J Neurol 136:2510-2526. doi:10.1093/brain/awt171
38. Rojo MG, Garcia GB, Mateos CP, Garcia JG, Vicente MC (2006) Critical comparison of 31 commercially available digital slide systems in pathology. Int J Surg Pathol 14:285-305. doi:10.1177/1066896906292274 (Pubitemid 44545765)
39. Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR (1997) Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA 277:813-817 (Pubitemid 27111317)
40. Sullivan SG, Greenland S (2013) Bayesian regression in SAS software. Int J Epidemiol 42:308-317. doi:10.1093/ije/dys213
41. Thal DR, Schultz C, Botez G et al (2005) The impact of argyrophilic grain disease on the development of dementia and its relationship to concurrent Alzheimer's disease-related pathology. Neuropathol Appl Neurobiol 31:270-279. doi:10.1111/j.1365-2990.2005.00635.x (Pubitemid 40769526)
42. Tzourio-Mazoyer N, Landeau B, Papathanassiou D et al (2002) Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. NeuroImage 15:273-289 (Pubitemid 34852226)
43. Uryu K, Nakashima-Yasuda H, Forman MS et al (2008) Concomitant TAR-DNA-binding protein 43 pathology is present in Alzheimer disease and corticobasal degeneration but not in other tauopathies. J Neuropathol Exp Neurol 67:555-564. doi:10.1097/NEN.0b013e31817713b5 (Pubitemid 351787082)
44. Whitwell JL, Josephs KA, Murray ME et al (2008) MRI correlates of neurofibrillary tangle pathology at autopsy: a voxel-based morphometry study. Neurology 71:743-749
45. Whitwell JL, Jack CR, Jr., Przybelski SA et al. (2011) Temporoparietal atrophy: A marker of AD pathology independent of clinical diagnosis. Neurobiol Aging 32:1531-1541
46. Whitwell JL, Dickson DW, Murray ME et al (2012) Neuroimaging correlates of pathologically defined subtypes of Alzheimer's disease: a case-control study. Lancet Neurol 11:868-877. doi:10.1016/S1474-4422(12)70200-4
47. WorkingGroup (1997) Consensus recommendation for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for Neuropathologic Assessment of Alzheimer's Disease. Neurobiol Aging 18:S1-S2
48. Zhang YJ, Xu YF, Cook C et al (2009) Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity. Proc Natl Acad Sci USA 106:7607-7612. doi:10.1073/pnas.0900688106